Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2007
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007US20070238741 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine
10/11/2007US20070238740 Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use
10/11/2007US20070238729 Dna-pk inhibitors
10/11/2007US20070238727 5-Substituted 1-Phenyl-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones and Analogs as Anti-Virals
10/11/2007US20070238726 Heterobicyclic pyrazole compounds and methods of use
10/11/2007US20070237818 Controlled-release formulation of HCV protease inhibitor and methods using the same
10/11/2007DE60022050C5 Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems Metabotropic glutamate receptor antagonists for treating diseases of the central nervous system
10/11/2007CA2647616A1 Process for preparing 6,7-dihydro-5h-imidazo[1,5-a]pyridin-8-one
10/11/2007CA2647605A1 Novel compound having heterocyclic ring
10/11/2007CA2646090A1 Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
10/11/2007CA2646088A1 Novel bi-aryl amines
10/11/2007CA2644963A1 Organic compounds
10/10/2007EP1841770A2 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
10/10/2007EP1841769A2 Purine derivatives compositions containing the same and use thereof against cancer
10/10/2007EP1841767A1 Pyrazolopyridines, their preparation and their medical use
10/10/2007EP1841766A1 Pyrrolopyridines useful in the treatment of inflammation
10/10/2007EP1841765A2 Imidazo[4,5-c]pyridine compound and method of antiviral treatment
10/10/2007EP1381608B1 Cyclohexylphenyl vasopressin agonists
10/10/2007EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist
10/10/2007EP1332132B1 Enamine derivatives as cell adhesion molecules
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007EP1300159B1 Remedies for cancer
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007CN101052640A Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
10/10/2007CN101052636A Compound containing fused ring and organic electroluminescent element employing the same
10/10/2007CN101052629A Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
10/10/2007CN101052399A Chemical compounds
10/10/2007CN101050215A Spiroazacyclic compounds as monoamine receptor modulators
10/10/2007CN101050214A New method for extracting Swainsonine from locoweed
10/10/2007CN101050199A (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
10/10/2007CN100341875C Novel process for producting imidazo[1,2-b]pyridazine derivative
10/10/2007CN100341874C Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof
10/10/2007CN100341873C Pyrido [2,3-d] pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
10/09/2007US7279580 For prophylaxis and therapy of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders
10/09/2007US7279575 Such as 2-(2-aminopyrimidin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one hydrochloride; for treatment of cell proliferative disorders/cancer; kits
10/09/2007US7279488 For therapy of acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, shock states induced by cytokine therapy (IL-2, TNF), organ transplantation and transplant rejection, head trauma, acute lung injury, ARDS, inflammatory skin conditions such as sunburn, inflammatory eye conditions
10/09/2007US7279487 Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors
10/09/2007US7279486 Therapy and prophylaxis of pain, central nervous system diseases; 2-Benzyl-3-(2,3-dihydro-1'H-spiro[indene-1,4'-piperidin]-1'-yl)propanoic acid trifluoroacetate
10/09/2007US7279484 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279469 Diaminotriazoles useful as inhibitors of protein kinases
10/09/2007US7279444 for controlling undesirable plants
10/09/2007US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif
10/04/2007WO2007112399A2 Tetrahydro-pyrazolo[3,4-c]pyridine cannabinoid modulators
10/04/2007WO2007110734A1 Process for the preparation of tadalafil
10/04/2007WO2007110500A1 Use of canthin-6-one and its analogues in the treatment of pathologies linked to mycobacteria
10/04/2007WO2007110364A1 Benzothiazoles having histamine h3 receptor activity
10/04/2007WO2007110216A1 Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
10/04/2007WO2007110215A1 Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase
10/04/2007WO2007079999A3 Pyridopyrazine derivatives and use thereof as modulators of the signal transduction paths
10/04/2007WO2007077490A3 Bicyclic heteroaryl compounds as pde10 inhibitors
10/04/2007WO2007076035A3 Anti-viral compounds
10/04/2007WO2007076034A3 Anti-viral compounds
10/04/2007WO2007076005A3 Processes and intermediates useful for preparing integrase inhibitor compounds
10/04/2007WO2007072164A3 Estrogen modulators
10/04/2007WO2007047671A3 Tetrahydroquinolines, synthesis thereof, and intermediates thereto
10/04/2007WO2007035620A3 Carbazole derivatives
10/04/2007WO2006108693A8 Process for preparing bicyclic compounds
10/04/2007WO2006107771A3 PYRAZOLO[3,4-c]QUINOLINES, PYRAZOLO[3,4-c]NAPHTHYRIDINES, ANALOGS THEREOF, AND METHODS
10/04/2007WO2006078331A3 Crystallization via high-shear transformation
10/04/2007US20070232805 Modified carbocyanine dyes and their conjugates
10/04/2007US20070232645 Anti-viral compounds
10/04/2007US20070232644 Inhibitors of the Hiv Integrase Enzyme
10/04/2007US20070232640 Antifungal and antiparasitic indoloquinoline derivates
10/04/2007US20070232636 schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, pre-eclampsia, nociception, visceral and neuropathic pain, pancreatitis, neurogenic inflammation, asthma, COPD and micturition disorders such as urinary incontinence
10/04/2007US20070232628 Calcium receptor antagonists; 2-(2-hydroxy-phenyl)-3-(4-isopropyl-phenyl)-5,6,7,8-tetrahydro-3H-quinazolin-4-one; bone disorders; hypoparathyroidism, osteosarcoma, periodontal disease, fracture healing, osteoarthritis, rheumatoid arthritis, Paget's disease, humoral hypercalcemia, osteoporosis
10/04/2007US20070232627 Anti-viral compounds
10/04/2007US20070232622 Small molecule toll-like receptor (TLR) antagonists
10/04/2007US20070232615 Chemical Compounds
10/04/2007US20070232600 Anti-migraine treatments
10/04/2007US20070232538 Uses of polypeptides
10/04/2007US20070227590 Supramolecular Complex of Pyridylnaphthalenediimide with Zinc Porphyrin Dendrimer Having Multiplicity of Artificial Photosynthetic Reaction Center
10/04/2007DE102006014688A1 Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen Azolopyridin-3-one derivatives as inhibitors of lipases, and phospholipases
10/04/2007DE102006014685A1 Imidazo-pyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholiphasen Imidazo-pyridin-2-one derivatives as inhibitors of lipases, and Phospholiphasen
10/04/2007CA2680789A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/04/2007CA2647425A1 Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
10/04/2007CA2647422A1 Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase
10/04/2007CA2646701A1 C-met protein kinase inhibitors for the treatment of proliferative disorders
10/04/2007CA2645581A1 Benzothiazoles having histamine h3 receptor activity
10/03/2007EP1839659A2 Chemicals compounds
10/03/2007EP1838805A1 Orthogonally fixed compounds for electrooptical applications
10/03/2007EP1838709A2 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-infective agents
10/03/2007EP1838708A2 Pyrrolodihydroisoquinolines as antiproliferative agents
10/03/2007EP1838707A1 Novel pyrrolodihydroisoquinolines as pde10 inhibitors
10/03/2007EP1838706A1 G-protein coupled receptor agonists
10/03/2007EP1838312A2 Chemical compounds
10/03/2007EP1838309A1 Chromane derivatives useful as acid pump antagonists
10/03/2007EP1838152A2 Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives
10/03/2007EP1758900B1 Substituted tricyclic benzimidazoles
10/03/2007EP1751157B1 Inhibitors of the hiv integrase enzyme
10/03/2007EP1490361B1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/03/2007CN101048414A Fused tricyclic derivatives for the treatment of psychotic disorders
10/03/2007CN101048407A Bicyclic heteroaryl PDE4B inhibitors
10/03/2007CN101048406A Novel substituted imidazole derivatives
10/03/2007CN101048405A Aryl-substituted piperazine derivatives
10/03/2007CN101048404A Process for preparation of 4-amino-1-isobutyl-1H-imidazo [4,5-c]-quinoline (imiquimod)
10/03/2007CN101048403A Heterocyclic antiviral compounds
10/03/2007CN101048388A Quinazolinone derivatives and their use as B-Raf inhibitors
1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 646